Reports and Briefs on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Myelodysplastic Syndrome: An Underserved Population Offers Commercial Opportunity

SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, a significant proportion of the MDS population will be left underserved by pharmacotherapy.

Published By Datamonitor
18 Oct 2005 $1900
Buy
Report
Report

Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines

This report explores key issues in pneumo-and meningococcal vaccines the seven major markets. It contains an analysis of epidemiological trends, in-depth assessment of currently marketed and pipeline vaccines and a ten-year sales forecast.

Published By Datamonitor
19 Oct 2010 $6400
Buy
Report
Report

Infectious Diseases Vaccine Market Overview

This report provides an overview of the vaccines industry with detailed profiles of the 5 major vaccine companies. It analyzes trends, sales, R&D and licensing strategies, portfolios and pipelines as well as other individual strengths & weaknesses.

Published By Datamonitor
25 Oct 2010 $6400
Buy
Report
Report

Pipeline Insight: Moderate-to-Severe Acute Pain - Positive outlook for opioid-sparing analgesics

Analysis of the future moderate to severe acute pain market with sales forecasts to 2019 across the seven major markets (US, Japan, 5EU) of key brands, generics, and pipeline products.

Published By Datamonitor
01 Nov 2010 $6400
Buy
Report
Report

Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity to new market entrants while Herceptin dominates the HER-2-positive market

Primary research-based analysis of the hormone receptor-positive breast cancer market. Includes epidemiology, patient segmentation, treatment trends, and future treatment scenarios. Separate coverage of triple-negative and HER-2-positive subsets.

Published By Datamonitor
03 Nov 2010 $6400
Buy
Report
Report

Stakeholder Opinions: Hepatocellular cancer

Stakeholder Opinions: Hepatocellular Cancer discusses issues in the treatment of hepatocellular cancer, highlighting potential target populations for drug developers, treatment limitations and unmet needs, and an overview of the current pipeline.

Published By Datamonitor
01 Dec 2010 $2800
Buy
Report
Report

Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive.

In-depth review of insulin developmental products for the treatment of diabetes, including an assessment of the commercial prospects of late-stage drugs, unmet market needs and sales forecasts to 2019.

Published By Datamonitor
08 Dec 2010 $3600
Buy
Report
Report

Forecast Insight: Antihypertensives - Fixed-dose combinations fail to offset generic erosion

Commercial analysis of the antihypertensive markets in the US, Japan, France, Germany, Italy, Spain, and the UK. Volume and revenue sales forecast to 2019.

Published By Datamonitor
08 Dec 2010 $6400
Buy
Report
Report

Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression

Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
09 Dec 2010 $6400
Buy
Report
Report

Pipeline Insight: Lung Cancers Overview – Intensive R&D activity but little improvement in patient outcomes

Overview of the current lung cancers clinical pipeline, including in-depth analysis of late-phase products, clinical trial data, sales forecasts through to 2019, Datamonitor drug assessment summaries and key opinion leader insight.

Published By Datamonitor
10 Dec 2010 $3600
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.